An Investigator Initiated Open-label and Explorative Study of Alefacept Treatment for Chronic Extensive Graft Versus Host Disease.
Phase of Trial: Phase I/II
Latest Information Update: 23 Apr 2015
At a glance
- Drugs Alefacept (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 20 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 09 Jun 2010 Planned end date changed from 1 Jan 2010 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 25 Nov 2006 New trial record.